Clinical relevance of mutant NPM1 and CEBPA in patients with acute myeloid leukaemia – preliminary report

AIM OF THE STUDY: Mutant NPM1 and CEBPA have been reported in patients with acute myeloid leukaemia (AML) and intermediate cytogenetic risk, and they appear to be associated with characteristic demographic and laboratory data, as well as clinical outcome. The objective of the study was to assess the...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Helbig, Grzegorz, Wozniczka, Krzysztof, Wieclawek, Agnieszka, Soja, Anna, Bartkowska-Chrobok, Aleksandra, Kyrcz-Krzemien, Slawomira
Médium: Artigo
Jazyk:Inglês
Vydáno: Termedia Publishing House 2014
Témata:
Original Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4171470/
https://ncbi.nlm.nih.gov/pubmed/25258581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2014.43490
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky